Gordon G. Giesbrecht
Operations Manager
Department of Clinical ScienceÂ
TABRANE PHARMACEUTICALS
Sri Lanka
Biography
he received training in Molecular Biology and conducted research work that included the identification and cloning of a novel member of the LDL receptor gene family, the LDL receptor-related protein (LRP). In 1989 Dr. Herz joined the Department of Molecular Genetics where in 1998 he attained his current position of Professor. He is the holder of the Thomas O. Hicks Family Distinguished Chair in Alzheimer’s Disease Research.
Research Interest
Cardiac autophagy,Cardiac inflammation,Mitochondria-targeted antioxidant therapy,Mitochondrial signaling,Sepsis-induced organ dysfunction
